Research study Program year 2025 Source: CMS Open Payments

Dreamm 7: A Multicenter, Open-Label, Randomized Phase III Study to Eva

Research payments

$3,529,432

518 payments

Through program year 2025, $3,529,432 in research payments was reported against Dreamm 7: A Multicenter, Open-Label, Randomized Phase III Study to Eva, across 518 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$113,965	88
2024	Research	$272,731	48
2023	Research	$1,308,397	115
2022	Research	$390,336	78
2021	Research	$1,289,770	157
2020	Research	$154,233	32

Breakdown

Who paid Research payments · program years 2020–2025

GlaxoSmithKline, LLC. $3,529,432 518 payments

Who received the money Research payments · program years 2020–2025

Bioclinica INC Organisation paid for research $970,400 1 payment
Kumc Research Institute INC Organisation paid for research $951,765 199 payments
US Oncology Research INC Organisation paid for research $612,206 50 payments
US Oncology ResearchLLC Organisation paid for research $293,743 86 payments
Yuma Regional Medical Center Specialty Clinics Organisation paid for research $262,715 49 payments
Gi Reviewers LLC Organisation paid for research $96,360 6 payments
University Of Utah Organisation paid for research $59,708 24 payments
Barbara Ann Karmanos Cancer Hospital Organisation paid for research $44,074 14 payments
Baylor Research Institute Organisation paid for research $37,251 17 payments
University Of North Carolina At Chapel Hill Organisation paid for research $31,707 7 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.